← Back to Search

Family-Informed Intervention for Obstructive Sleep Apnea in Children with Down Syndrome

N/A
Recruiting
Research Sponsored by University of Miami
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Naive to PAP treatment
Children are able to cooperate with testing
Must not have
Caregivers who do not speak English well enough to complete behavioral and performance measures
Child with previously treated with PAP
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 6 months, and 12 months
Awards & highlights
No Placebo-Only Group

Summary

This trial will compare a family-informed intervention to standard care for children with obstructive sleep apnea and Down Syndrome, to see if the intervention is more effective over a 12 month period.

Who is the study for?
This trial is for children aged 6-18 with Down Syndrome and obstructive sleep apnea who haven't used PAP treatment before. They must be able to do tests and have a clinical referral for PAP. It's not for kids in foster care, those treated with PAP already, or with major illnesses like leukemia or severe heart disease.
What is being tested?
The study compares the effectiveness of a family-informed intervention versus standard clinical care over twelve months in treating sleep apnea in children with Down Syndrome.
What are the potential side effects?
Since this trial involves non-medical interventions (family-informed support vs standard care), there are no direct medical side effects listed; however, discomfort or resistance to therapy could occur.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
I have never received PAP treatment.
Select...
My child can follow instructions for tests.
Select...
I am between 6 and 18 years old.

Exclusion Criteria

You may be eligible for the trial if you check “No” for criteria below:
Select...
I am a caregiver and I do not speak English well enough for medical assessments.
Select...
My child was previously treated with PAP.
Select...
I do not have major illnesses like leukemia or severe heart disease.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~6 months, and 12 months
This trial's timeline: 3 weeks for screening, Varies for treatment, and 6 months, and 12 months for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Effect of PAP adherence in children with DS and OSAS on patient-centered outcomes and family-relevant outcomes identified during the R61 phase of this research
Effect of PAP adherence on quality of life and neurobehavioral outcomes
Efficacy of CON in promoting PAP adherence
+1 more

Awards & Highlights

No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.

Trial Design

2Treatment groups
Active Control
Group I: Family-informed intervention (INT)Active Control1 Intervention
Multiple face-to-face visits, telephone calls and-person visits with the PAP psychologist and team.
Group II: Standard Clinical CareActive Control1 Intervention
Support which is given as part of the standard clinical care for patients who are currently prescribed PAP.

Find a Location

Who is running the clinical trial?

University of MiamiLead Sponsor
949 Previous Clinical Trials
428,371 Total Patients Enrolled
Children's Hospital Medical Center, CincinnatiOTHER
837 Previous Clinical Trials
6,565,251 Total Patients Enrolled
University of PennsylvaniaOTHER
2,079 Previous Clinical Trials
42,721,535 Total Patients Enrolled

Media Library

Family-informed intervention Clinical Trial Eligibility Overview. Trial Name: NCT04132999 — N/A
Obstructive Sleep Apnea Research Study Groups: Family-informed intervention (INT), Standard Clinical Care
Obstructive Sleep Apnea Clinical Trial 2023: Family-informed intervention Highlights & Side Effects. Trial Name: NCT04132999 — N/A
Family-informed intervention 2023 Treatment Timeline for Medical Study. Trial Name: NCT04132999 — N/A
~19 spots leftby Jan 2026